PixCell Medical Partners with Triolab

PixCell Medical has announced a partnership with Triolab, to be the sole distributor in Sweden of the HemoScreen, PixCell’s haematology analyser designed for use at the point of care.

Johan Snis, Sales Manager at Triolab, said: “PixCell’s HemoScreen brings lab-quality haematology results closer to the patient, making it possible to analyse Complete Blood Count (CBC) with the five-part differential at a patient’s bedside, without the skills of a biomedical scientist, which is a prerequisite for traditional haematology. We have already seen evidence on how this can increase patient safety, enhance the patient experience by shortening the time spent in accident and emergency departments, and give great support to the doctors in primary care to make the right decision quicker. This is all possible due to the low-quality control, maintenance-free, all-in-one cartridge system.”

HemoScreen, developed by PixCell Medical, is the only five-part differential CBC analyser that is both FDA-cleared and CE-marked for point-of-care use. Including a disposable cartridge with all necessary reagents, the HemoScreen requires no maintenance or calibration and does not need to be operated by a medically trained professional. With one drop of blood and within six minutes, the HemoScreen delivers CBC results with 20 standard CBC parameters. 

Triolab Group is the largest independent distributor of in-vitro diagnostic in the Nordics and Baltics.